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Background
Generations of biogerontologists have repeatedly
observed striking variations in lifespans among indivi-
dual members of genetically identical cohorts from a
wide variety of species when aged under apparently
identical environments. It is a reasonable assumption
that these differences are accompanied by contrasting
patterns of healthspan. Recent studies with C. elegans
provide strong evidence that these lifespan variations are
largely non-heritable (SL Rea et al., Nature Genet37:894,
2005). One can therefore, conclude that they are driven
by stochastic events.
Methods
The frequencies of somatic mutation seem insufficient to
explain these variations. They seem likely to be epigeneti-
cally based. I have suggested an explanation (GM Martin,
Aging Cell 8:761, 2009) that can be viewed as an extension
of the antagonistic pleiotropic model of aging proposed by
the late George C. Williams (Evolution 11: 398, 1957). In
brief, it is proposed that variegated gene expression within
families of homologous cells was selected by evolution as
an adaptive trait to ensure survival within unpredictable
ecologies.
Results
Species that evolved within ecologies with high degrees
of environmental challenges were thought to have devel-
oped more marked degrees of “epigenetic gambling”
than those that evolved under more predictable
ecologies. Once established, however, variable degrees of
“epigenetic drift” accompany aging, resulting in non-
adaptive pathophysiology that escapes the force of nat-
ural selection. One would therefore predict that species
with higher degrees of initial epigenetic gambling would
exhibit shorter lifespans. Evidence for such epigenetic
drift has been established among human identical twins
(MF Fraga et al., PNAS 102:10604, 2005) and inbred
mice (R Bahar et al., Nature 441:1011, 2006). This sce-
nario could provide an explanation for the quasi-
stochastic distributions of the lesions of a variety of neu-
rodenerative disorders, including forms of Parkinson’s
disease, frontotemporal dementias and dementias of the
Alzheimer type (DAT). For the case of DAT, for example,
one can envisage “ap e r f e c ts t o r m ” whereby epigenetic
drifts have resulted in cell foci having exceptionally low
levels of alpha secretase, neprilysin and insuling-degrad-
ing enzyme while, at the same time, developing excep-
tionally high levels of beta secretase, gamma secretase
and gamma secretase activating enzyme.
Conclusion
The theory also predicts analogous pathogenetic
mechanisms for a wide variety of geriatric disorders,
including benign and malignant neoplasms, in which the
first step in oncogenesis could be an escape from prolif-
erative homeostasis leading to hyperplastic clones. Sup-
port for this idea comes from studies of expansions of
clones with neutral mutations surrounding adenocarci-
nomas of the colon (JJ Salk et al., PNAS 106:20871,
2009).
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